Changwan Ryu
Impact in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Pulmonary Hypertension Research and Treatments
- Electrochemistry top 10%
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 18
- Pulmonary Hypertension Research and Treatments 3
- Tracheal and airway disorders 2
- Physiology 10
- Sarcoidosis and Beryllium Toxicity Research 10
- Co-authors
- Erica L. Herzog (23 shared papers)Mridu Gulati (10 shared papers)Robert Homer (8 shared papers)Naftali Kaminski (9 shared papers)Jose D. Herazo‐Maya (4 shared papers)Hyun S. Ahn (4 shared papers)Hongyi Pan (5 shared papers)Danielle E Antin-Ozerkis (2 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (7 papers)CHEST Journal (5 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (4 papers)JCI Insight (3 papers)European Respiratory Journal (3 papers)
- Partner nations
- United StatesSouth KoreaGermany
In The Last Decade
Changwan Ryu
49 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 551
- Electrochemistry 19
- Physiology 141
- Immunology 90
- Pathology and Forensic Medicine 75
Countries citing papers authored by Changwan Ryu
This map shows the geographic impact of Changwan Ryu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changwan Ryu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changwan Ryu more than expected).
Fields of papers citing papers by Changwan Ryu
This network shows the impact of papers produced by Changwan Ryu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changwan Ryu. The network helps show where Changwan Ryu may publish in the future.
Co-authors
The 25 scholars most cited alongside Changwan Ryu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 149 | |
| 2 | 2016 | 100 | |
| 3 | 2022 | 88 | |
| 4 | 2019 | 86 | |
| 5 | 2017 | 73 | |
| 6 | 2019 | 71 | |
| 7 | 2021 | 57 | |
| 8 | 2020 | 55 | |
| 9 | 2021 | 53 | |
| 10 | 2020 | 48 | |
| 11 | 2023 | 48 | |
| 12 | 2016 | 47 | |
| 13 | 2024 | 47 | |
| 14 | 2020 | 28 | |
| 15 | 2022 | 24 | |
| 16 | 2021 | 21 | |
| 17 | 2022 | 21 | |
| 18 | 2021 | 19 | |
| 19 | 2024 | 19 | |
| 20 | 2020 | 17 |
About Changwan Ryu
Changwan Ryu is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Pathology and Forensic Medicine, Otorhinolaryngology and Renewable Energy, Sustainability and the Environment, having authored 50 papers that have together received 1.2k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers), Sarcoidosis and Beryllium Toxicity Research (10 papers), Systemic Sclerosis and Related Diseases (6 papers), Pulmonary Hypertension Research and Treatments (3 papers), Tracheal and airway disorders (2 papers), Long-Term Effects of COVID-19 (2 papers), CO2 Reduction Techniques and Catalysts (2 papers) and Sinusitis and nasal conditions (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (551 citations), Electrochemistry (19 citations), Physiology (141 citations), Immunology (90 citations) and Pathology and Forensic Medicine (75 citations). Changwan Ryu has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Erica L. Herzog, Mridu Gulati, Robert Homer, Naftali Kaminski, Jose D. Herazo‐Maya, Hyun S. Ahn, Hongyi Pan, Danielle E Antin-Ozerkis, John Hwa and Koji Sakamoto. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, JCI Insight and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.